219 related articles for article (PubMed ID: 27572289)
1. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
[TBL] [Abstract][Full Text] [Related]
2. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
Yu H; Baser O; Wang L
BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
Rodrigues R; Barber GE; Ananthakrishnan AN
Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
[TBL] [Abstract][Full Text] [Related]
4. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
Mehrotra P; Jang J; Gidengil C; Sandora TJ
Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
[TBL] [Abstract][Full Text] [Related]
5. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
[TBL] [Abstract][Full Text] [Related]
6. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
[TBL] [Abstract][Full Text] [Related]
7. Attributable costs and length of stay of hospital-acquired
Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
[TBL] [Abstract][Full Text] [Related]
8. The burden of Clostridium difficile in surgical patients in the United States.
Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
[TBL] [Abstract][Full Text] [Related]
10. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.
Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD
Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675
[TBL] [Abstract][Full Text] [Related]
11. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
12. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.
Nanwa N; Sander B; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Kwong JC
PLoS One; 2017; 12(3):e0172410. PubMed ID: 28257438
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
Gabriel L; Beriot-Mathiot A
J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
[TBL] [Abstract][Full Text] [Related]
14. The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.
Nanwa N; Kwong JC; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Sander B
Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1068-78. PubMed ID: 27322606
[TBL] [Abstract][Full Text] [Related]
15. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
Mollard S; Lurienne L; Heimann SM; Bandinelli PA
J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
[TBL] [Abstract][Full Text] [Related]
16. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
Zhang D; Prabhu VS; Marcella SW
Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
[TBL] [Abstract][Full Text] [Related]
18. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
Olsen MA; Young-Xu Y; Stwalley D; Kelly CP; Gerding DN; Saeed MJ; Mahé C; Dubberke ER
BMC Infect Dis; 2016 Apr; 16():177. PubMed ID: 27102582
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital.
Jacob J; Wu J; Han J; Nelson DB
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):294-299. PubMed ID: 27923419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
